← Back to Search

Clinical Decision Support

Clinical Decision Support for Respiratory Infections

N/A

Waitlist Available

Led By Devin Mann

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients must have been seen at a participating clinic with a complaint of cough or sore throat

Be older than 18 years old

Must not have

Patients with a history of chronic lung disease or immunosuppression will be excluded since the CPRs were not validated in these groups

Individuals who are unable or unwilling to provide informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 6, month 12

Awards & highlights

No Placebo-Only Group

Summary

This trial found that using a new clinical prediction tool helped nurses more accurately prescribe antibiotics for patients with respiratory infections.

Who is the study for?

This trial is for patients aged 3-70 with sore throat and 18-70 with cough, seen at participating clinics. Nurses prescribing treatment must work at least half-time, be licensed, use the clinic's EHR system regularly, and see a sufficient number of patients to maintain skills.

What is being tested?

The study tests an integrated clinical prediction tool in electronic health records (EHR) that helps nurses decide when antibiotics are needed for acute respiratory infections. It aims to ensure prescriptions are evidence-based.

What are the potential side effects?

Since this trial involves a decision-support tool rather than medication or procedures, there aren't direct side effects like those associated with drugs or medical treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I visited a clinic for a cough or sore throat.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have chronic lung disease or a weakened immune system.

Select...

I am unable or unwilling to give my consent for participation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 6, month 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 6, month 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 6, month 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in number of Acute Respiratory Infection(ARI) encounters

Number of Participants Who Perceive the iCPR Tool as Useful.

Secondary study objectives

Change in Job Satisfaction of RNs and physicians

Number of nurse triage encounters completed

Number of patients requiring repeat healthcare visits

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: iCPR groupExperimental Treatment1 Intervention

Clinic personnel (Providers and Nurses) will receive online training that includes: 1) an overview of the project; 2) iCPR workflows including triage; 3) CPR component review and risk categories; 4) history and physical examination components of the CPRs. The online training will be followed by in-person training to reinforce the online training and teach additional skills. In-person training sessions led by study team will last approximately 60 minutes, and consist of four basic components: 1) a review of the iCPR ARI protocol and tools; 2) on-screen walk-throughs of common scenarios employing the new tools; 3) physical examination technique practice with simulated patients; A 60-minute in-person follow-up nurse training will take place 4-6 weeks after implementation of the intervention.

Group II: Control no intervention groupActive Control1 Intervention

standard care will continue as usual.

0 / 3Eligibility criteria met